IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,628,173 | +310.8% | 410,674 | +271.6% | 0.02% | +300.0% |
| Q2 2023 | $4,534,471 | +27.7% | 110,516 | +11.5% | 0.01% | +20.0% |
| Q1 2023 | $3,549,518 | -57.2% | 99,117 | -48.4% | 0.01% | -61.5% |
| Q4 2022 | $8,292,290 | -99.9% | 192,223 | +44.8% | 0.01% | +44.4% |
| Q3 2022 | $5,871,090,000 | +32.2% | 132,740 | +10.6% | 0.01% | +28.6% |
| Q2 2022 | $4,441,289,000 | -8.4% | 119,970 | +31.4% | 0.01% | 0.0% |
| Q1 2022 | $4,849,869,000 | -54.8% | 91,336 | -70.2% | 0.01% | -53.3% |
| Q4 2021 | $10,725,145,000 | +389.5% | 306,715 | +1073.9% | 0.02% | +400.0% |
| Q3 2021 | $2,191,235,000 | +158.3% | 26,128 | +22.9% | 0.00% | +200.0% |
| Q2 2021 | $848,341,000 | -34.1% | 21,267 | -25.7% | 0.00% | -50.0% |
| Q1 2021 | $1,287,654,000 | -59.9% | 28,640 | -49.6% | 0.00% | -66.7% |
| Q4 2020 | $3,214,469,000 | +42.0% | 56,853 | +21.7% | 0.01% | +100.0% |
| Q3 2020 | $2,264,219,000 | -82.2% | 46,728 | -27.4% | 0.00% | -87.0% |
| Q2 2020 | $12,713,722,000 | +19.2% | 64,361 | -12.9% | 0.02% | +4.5% |
| Q1 2020 | $10,668,732,000 | +30.4% | 73,883 | -45.5% | 0.02% | +46.7% |
| Q4 2019 | $8,183,501,000 | +172.1% | 135,466 | +169.8% | 0.02% | +200.0% |
| Q3 2019 | $3,007,542,000 | +3.0% | 50,201 | +10.5% | 0.01% | -16.7% |
| Q2 2019 | $2,919,208,000 | +127.5% | 45,421 | +187.3% | 0.01% | +100.0% |
| Q1 2019 | $1,283,135,000 | -21.8% | 15,808 | -47.9% | 0.00% | -25.0% |
| Q4 2018 | $1,641,262,000 | +53.1% | 30,360 | +46.1% | 0.00% | +100.0% |
| Q3 2018 | $1,072,193,000 | +50.1% | 20,787 | +21.3% | 0.00% | +100.0% |
| Q2 2018 | $714,099,000 | +16.7% | 17,137 | +23.5% | 0.00% | 0.0% |
| Q1 2018 | $611,874,000 | +15.2% | 13,881 | +31.4% | 0.00% | 0.0% |
| Q4 2017 | $531,269,000 | -24.0% | 10,562 | -23.4% | 0.00% | -50.0% |
| Q3 2017 | $698,798,000 | -20.4% | 13,783 | -20.1% | 0.00% | -33.3% |
| Q2 2017 | $877,609,000 | +64.1% | 17,252 | +29.7% | 0.00% | +200.0% |
| Q1 2017 | $534,901,000 | -45.9% | 13,306 | -35.6% | 0.00% | -80.0% |
| Q4 2016 | $987,977,000 | -47.2% | 20,656 | -59.6% | 0.01% | -37.5% |
| Q3 2016 | $1,872,304,000 | +343.7% | 51,100 | +182.0% | 0.01% | +300.0% |
| Q2 2016 | $421,968,000 | -32.0% | 18,118 | +18.3% | 0.00% | -33.3% |
| Q1 2016 | $620,217,000 | -66.4% | 15,314 | -48.6% | 0.00% | -25.0% |
| Q4 2015 | $1,845,762,000 | – | 29,804 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |